Commercial Solutions in Life Sciences from a Data Perspective - with Jane Chen of Novartis

episode

The AI in Business Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Booked out doesn't mean you're ready for an associate OD 23 min · 23 Sep 2026 · The Optometry Success Podcast

NXT Reaction: Lexis King & His Birthright 29 min · 23 Sep 2026 · Busted Open

NPR News: 09-22-2026 11PM EDT 4 min · 23 Sep 2026 · NPR News Now

11PM ET 09/22/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

Best of NFL Week 2 Part 1: Jayden Daniels HURT + Caleb Williams OVERREACTION + Chiefs look like their OLD SELVES 1h 11m · 23 Sep 2026 · Nightcap

Best of NFL Week 2 Part 1: Jayden Daniels HURT + Caleb Williams OVERREACTION + Chiefs look like their OLD SELVES 1h 13m · 23 Sep 2026 · Club Shay Shay

Report any issue

Source

Recorded07 Aug 2024

Publishertechemergence.libsyn.com ↗

Handlerec:6020984

Show notes

Today's guest is Jane Chen, Director of Commercial Analytics for Women's Cancer at Novartis. Jane joins us on the program today to highlight challenges in identifying and segmenting specific patient groups, particularly those with rare or niched diseases. Throughout the episode, she sheds a spotlight on privacy concerns in healthcare data, including blind spots due to HIPAA regulations. Later, she explains the ways healthcare leaders are testing the waters for generative AI applications in healthcare. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in